Paper
Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
Published Sep 28, 2006 · Chi-Keung Wan, Guo‐Yuan Zhu, Xiao-Ling Shen
Biochemical pharmacology
Q1 SJR score
80
Citations
6
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro Study
Highly CitedStudy Snapshot
Gomisin A reverses multidrug resistance in Pgp-overexpressing HepG2-DR cells by altering Pgp-substrate interaction without altering Pgp expression.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
Pgp modulators like cis-(Z)-flupentixol disrupt molecular cross talk between substrate and ATP sites, potentially affecting drug transport and resistance in cancer and infectious diseases.
2006·18citations·Nazli Maki et al.·Biochemistry
Biochemistry
Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation
Honokiol suppresses NF-B activation and NF-B-regulated gene expression through the inhibition of IKKs, potentially explaining its anti-tumor effects.
2005·116citations·A. Tse et al.·Biochemical Pharmacology
Biochemical Pharmacology
Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs.
The two-site drug binding model for P-glycoprotein requires modification, as both LDS-751 and rhodamine 123 bind simultaneously to the protein, potentially within a hydrophobic pocket.
2005·82citations·Miguel R. Lugo et al.·Biochemistry
Biochemistry
Schisandrin B--a novel inhibitor of P-glycoprotein.
Schisandrin B, a naturally occurring compound from Schisandra chinensis, effectively inhibits P-glycoprotein, reversing cancer multidrug resistance and restoring intracellular drug accumulation.
2005·65citations·Q. Pan et al.·Biochemical and biophysical research communications
Biochemical and biophysical research communications
Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug Efflux
P-glycoprotein plays a crucial role in drug efflux and contributes to multidrug resistance in AIDS/HIV and cancer chemotherapy, with recent progress in understanding its structure and mechanism.
2005·212citations·T. Loo et al.·The Journal of Membrane Biology
The Journal of Membrane Biology
Citations
Comprehensive Insights into Herbal P-Glycoprotein Inhibitors and Nanoformulations for Improving Anti-Retroviral Therapy Efficacy.
Herbal P-glycoprotein inhibitors and nanoformulations can improve anti-retroviral therapy efficacy by increasing oral bioavailability and reducing toxicity, boosting patient compliance and lowering costs.
2024·0citations·Prexa Jain et al.·Journal of drug targeting
Journal of drug targeting
Design and Synthesis of Cyclolipopeptide Mimics of Dysoxylactam A and Evaluation of the Reversing Potencies against P-Glycoprotein-Mediated Multidrug Resistance.
Cyclolipopeptide 56, a structurally simplified compound, effectively reverses P-glycoprotein-mediated multidrug resistance in cancer cells by inhibiting P-gp transport function without causing toxicity.
2024·0citations·Guan-Zhou Yang et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Novel Benzo Five-Membered Heterocycle Derivatives as P-Glycoprotein Inhibitors: Design, Synthesis, Molecular Docking, and Anti-Multidrug Resistance Activity.
D7 shows potential as a multidrug resistance reveal agent by inhibiting P-glycoprotein efflux, achieving stronger antitumor activity when combined with doxorubicin.
2023·9citations·Zhikun Yang et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Modular Biomimetic Strategy Enabled Discovery of Simplified Pseudo-Natural Macrocyclic P-Glycoprotein Inhibitors Capable of Overcoming Multidrug Resistance.
A modular biomimetic strategy successfully created new macrocycles that effectively inhibit P-glycoprotein and reverse multidrug resistance in cancer cells, offering promising leads for future antitumor treatments.
2023·7citations·Bo Liu et al.·Journal of medicinal chemistry
Journal of medicinal chemistry
Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer
The combination of paclitaxel and the ROS inhibitor Gomisin A may be a novel strategy in ovarian cancer chemotherapy by suppressing oxidative stress and inhibiting cell cycle progression.
2022·8citations·Taiwei Wang et al.·Oncology Reports
Oncology Reports
Prediction of tacrolimus and Wuzhi tablet pharmacokinetic interaction magnitude in renal transplant recipients
Wuzhi tablets increase the bioavailability of tacrolimus in renal transplant recipients, potentially reducing the need for tacrolimus doses.
2022·3citations·Pan Chen et al.·Clinical Transplantation
Clinical Transplantation
An ester derivative of tenacigenin B from Marsdenia tenacissima (Roxb.) Wight et Arn reversed paclitaxel-induced MDR in vitro and in vivo by inhibiting both P-gp and MRP2.
MT2 from Marsdenia tenacissima can potentially reverse multidrug resistance in tumors by suppressing P-gp and MRP2 expression and directly inhibiting P-gp transport function.
2022·9citations·Zhou Wu et al.·Journal of ethnopharmacology
Journal of ethnopharmacology
A Comprehensive Review of the Main Lignan Components of Schisandra chinensis (North Wu Wei Zi) and Schisandra sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities
Wu Wei Zi's lignan components may cause drug-drug interactions, highlighting the need for further research on their safety and interactions with other drugs.
2022·13citations·Feng Zhang et al.·Frontiers in Pharmacology
Frontiers in Pharmacology
Anti-Cancer Effects of α-Cubebenoate Derived from Schisandra chinensis in CT26 Colon Cancer Cells
-cubebenoate from Schisandra chinensis can stimulate apoptosis and inhibit colon cancer cell migration by regulating MAPK, PI3K/AKT, and FAK/MLC signaling pathways.
2022·4citations·J. Gong et al.·Molecules
Molecules